Escherichia coli were labeled with wFe and then either treated with myeloperoxidase, H , O , , and chloride or opsonized and mixed with human neutrophils. The myeloperoxidase system at pH 7.4 caused release of most of the bacterial 69Fe. A similar result has been obtained by Rosen and Klebanoff (J Biol Chem 257:13731. 1982) but at pH 5. Iron release at pH 7.4 did not require the presence of a chelator, and the majority passed through a 10, OOO relative molecular mass cut-off ultrafiltration membrane. When iron-poor lactoferrin was present during incubation with myeloperoxidase, 88% of the released "Fe was precipitated with anti-lactoferrin antiserum, indicating that it was lactoferrin-bound. When the bacteria were mixed with neutrophils in a 101 ratio, approximately 50% were phagocytosed. About 40% of the wFe was released from the ACTOFERRIN IS A constituent of specific granules of L neutrophils and is released both into phagosomes and extracellularly when the cells are stimulated.'-' Most lactoferrin is present in an iron-deplete form.4 Lactoferrin can inhibit myelopoiesis5 and enhance neutrophil adhesion: but whether these are its major roles or whether it has other important functions in the neutrophil is not clearly understood.' By depriving microorganisms of the iron they need for growth, lactoferrin can be bacteriostatic,'" and bactericidal activity has been reported.8." Bullen and Armstrong" have shown that when neutrophil lactoferrin is saturated, bacteria that survive the killing process are able to grow within the cells. Ambruso and Johnston" have proposed that lactoferrin can aid oxidative killing by neutrophils by catalyzing a Fenton-type reaction between superoxide and H,O,. However, subsequent studies have demonstrated that iron bound to lactoferrin does not catalyze this rea~tion.".'~ It may in fact limit hydroxyl radical production by neutrophils provided with an exogenous iron catalyst," and an anti-oxidant role for lactoferrin has been proposed.I6
0006-4971/90/7504-0004$3.00/0 ingested bacteria over a 40-minute period. Initially, most remained associated with the neutrophil phagosomes, but with time, there was gradual transfer of some of the iron to the medium. Using anti-lactoferrin antiserum, 50% to 60% of phagosomal iron and 64% to 71 % of iron in the medium was shown to be bound to lactoferrin. Thus, iron is released from phagocytosed E coli. Most becomes bound to lactoferrin, and some of this is released into the surroundings of the neutrophils. This suggests that neutrophil lactoferrin may function to trap iron from ingested microorganisms, enabling its removal from sites of inflammation. This may prevent iron from catalyzing undesirable oxidative reactions, as well as making it unavailable for growth of microorganisms that survive the killing process. 0 1990 by The American Society of Hematology.
release most of their iron in a low relative molecular mass (Mr) form.
The purpose of this study was to determine, using 59Fe-labeled Escherichia coli, whether iron is released when bacteria are phagocytosed and killed by neutrophils and, if so, whether the released iron is taken up by lactoferrin. We have looked first a t release of iron from E coli exposed to a cell-free MPO system, similar to that of Rosen and Klebanoff'* but at pH 7, and at uptake by lactoferrin under these conditions.
METHODS

Materials.
Human lactoferrin (approximately 90% pure) and transferrin (both substantially iron-free) were obtained from the Sigma Chemical Co (St Louis, MO). MPO purified from human neutrophils19 had a purity index (A430/A280) greater than 0.7. 59FeC13 was purchased from New England Nuclear (North Ryde, NSW, Australia). Rabbit antibodies to human lactoferrin, transferrin, and IgA were from Dakopatts A/S, Copenhagen, Denmark. Other biochemicals were from Sigma. Reactions were carried out in 10 mmol/L phosphate buffer, pH 7.4, containing 0.14 mol/L NaCl (PBS). For experiments involving neutrophils, 1 mmol/L CaCI,, 1 mmol/L MgCI,, and 5 mmol/L glucose were added (PBSG).
Neutrophils were separated from human blood of healthy donors by Ficoll-Hypaque centrifugation, dextran sedimentation, and hypotonic lysis of contaminating red blood cells.20 The cells were resuspended in PBSG at 107/mL. E coli were grown overnight at 3IaC with aeration in L broth (2 g bacto tryptone, 1 g bacto yeast extract; both from Difco Laboratories, Detroit, MI; 1 g NaCl and 160 mg glucose per 200 mL).*' A sample (50 pL) of the culture was added to 5 mL of L broth containing 20 pCi 59Fe and cultured for a further 2 to 3 hours. The total iron content of the medium measured by reduction and reaction with ferrozine2' was 8 to 13 pmol/L. The labeled E coIi were harvested in log phase growth, sedimented at 5,OOOg for 10 minutes, washed twice with cold PBS, resuspended in PBSG (approximately 5 mL) at 5 x 108/mL, and used with minimal delay. Routinely, 5% to 10% of the "Fe was incorporated into the bacteria. Initially, the labeled bacteria were given an additional wash in PBS containing 0.1 mmol/L EDTA. This scarcely decreased the amount of radioactivity associated with the bacteria, indicating that very little iron was bound to the outside of the cells, and subsequently this step was not included. E coli numbers were determined from the Neutrophils.
S9Fe-labeled E coli.
turbidity of the suspension, having first calibrated turbidity against a plating assay.
59Fe-labeled bacteria were incubated for 5 minutes at 37OC in PBS with 10% human serum containing full complement activity, washed once with 10 mL cold PBS, and then resuspended in PBS at 5 x 108/mL.
Experiments were performed with opsonized and unopsonized E coli. "Fe-labeled E coli were suspended at 5 x 107/mL (approximately 4 x IO4 cpm/mL) in either 40 mmol/L acetate buffer (pH 5.0, containing 0.1 mol/L NaCI) or in PBS. MPO (50 nmol/L, approximately 16 mU/mL) and H,O, were added and the suspensions mixed by rotation for 40 minutes at 37OC. At pH 5, one addition of 50 pmol/L H202 was added at the start of the incubation. At pH 7.4, up to four additions of 50 pmol/L H,O, were made at intervals during the first 25 minutes. This was to maintain a low concentration of H,O, and thus ensure efficient MPO-dependent conversion to HOCl." E coli were pelleted by centrifugation at 5,OOOg for 10 minutes, washed twice, and the counts in the supernatants and pellets determined. In some experiments, lactoferrin or transferrin was present, and the "Fe bound to either protein determined by immunoprecipitation of the supernatant (see below).
Two types of experiments were performed. Neutrophils were mixed with E coli and either the fate of the iron label was followed without separating nonphagocytosed bacteria, or the nonphagocytosed bacteria were removed after 10 minutes, and the neutrophils and ingested bacteria were resuspended and incubated. The protocol is shown schematically in Fig 1. Opsonized "Fe-labeled E coli (10') were added to neutrophils (IO7) in 1 mL PBSG, and the tubes were tumbled gently at 37OC. Noningested bacteria were separated from the neutrophils and ingested bacteria by 5 minutes' centrifugation at 1OOg. Preliminary experiments showed that all the neutrophils and less than 2% of E coli in suspension were sedimented under these conditions. Low speed supernatants were centrifuged at 5,OOOg for 10 minutes to sediment the noningested bacteria (Pl), leaving high speed supernatants (Sl) containing soluble 59Fe. Low speed pellets were washed and then treated with 0.5 mL PBS containing 0.05% saponin, which lyses the neutrophils but not E coli,2' to release soluble 59Fe from the
Upsonization.
Treatment of E coli with myeloperoxidase.
Phagocytosis of S9Fe-labeled E coli. phagosomes. After approximately 10 minutes, the tubes were spun at full speed for 2 minutes in a microfuge, resulting in a pellet containing ingested bacteria (P2) and supernatant containing intraphagosomal and soluble intracellular neutrophil components (S2). 59Fe present in each fraction was determined, using an LKB Compugamma counter.
In the first protocol, suspensions were incubated for 40 minutes during which time samples were removed at regular intervals. In the second protocol, neutrophils were separated from nonphagocytosed bacteria after 10 minutes by centrifugation at IOOg, washed once, resuspended in the same volume of PBSG, and incubated for a further 40 minutes with regular sampling. Zero time samples constituted neutrophils and E coli that were mixed at O°C (to prevent phagocytosis) and, after a few minutes, treated like the other samples.
Ultrafiltration of bacterial supernatants or sonicates was done using Centricon 100 microconcentrators (10,000 Mr cutoff) from Amicon Corp, Danvers, MA.
Lactoferrin-bound "Fe was measured either in the supernatants of bacteria exposed to the MPO system in the presence of lactoferrin or in supernatants (S1 and S2) after phagocytosis of E coli by neutrophils. To an appropriate volume of each sample (0.2 mL of MPO supernatant, 0.6 to 1 mL of SI, 0.25 to 0.45 mL of 52) was added sufficient specific anti-lactoferrin antiserum to precipitate either all the lactoferrin added (MPO experiments) or that theoretically present from the neutrophils, assuming 6 pg/107 c e k 7 Protein A-Sepharose (1.25 mg/lO pL antiserum) and 0.4 mg casein in 0.2 mL PBS were added, and samples were gently rotated at 4OC overnight in sealed Eppendorf tubes. Sepharosebound immunoprecipitates were spun down, washed twice, and counted. A similar procedure was carried out with anti-IgA antiserum, to act as a negative control. The usual immunoprecipitation buffers containing detergent and guanidine hydrochloride were avoided because of the risk of dissociating bound iron, and casein was included to minimize nonspecific iron binding to the immunoglobulin or protein A-Sepharose. "Fe precipitated by anti-IgA was always less than 2% of the total counts, and anti-lactoferrin precipitated less than 1% of the counts in an E coli sonicate, demonstrating the specificity of the method. A similar procedure was carried out using
Ultrafiltration.
Immunoprecipitation. 
RESULTS
Release of 59Fe from E coli exposed to the myeloperoxidase system. Rosen and Klebanoffl' exposed E coli to MPO, H,O,, and CI-at pH 5, and observed release of bacterial iron that was enhanced by chelators such as citrate. Most of the iron was in a low Mr form. We measured release of 26.4 f 3.2% (mean * S.D. for four determinations) of the total E coli iron on adding the MPO system, compared with 4.5 * 0.7% when the E coli were incubated alone. In agreement with Rosen and Klebanoff, release increased to 80% in the presence of citrate (1 mmol/L), but apolactoferrin (30 pg/mL) had no effect on the amount of 59Fe solubilized. This may reflect less accessibility than citrate, since lactoferrin should retain its iron binding capacity at this pH."
When neutrophils ingest particles, the pH within the phagosomes gradually falls below 6. However, at least two s t~d i e s~~*~' indicate that there is an initial period when the pH remains near neutral. Since much of the bactericidal activity takes place during the first few minutes,2'*26 the effect of the MPO system on E coli was also investigated at pH 7.4. MPO, although exhibiting a low pH optimum, is still efficient at converting H,O, to HOCl in neutral solution, especially when H,O, is continuously generated and its steady state concentration remains
The results of exposing E coli to the MPO system at pH 7.4 are shown in Table 1 . Background release of 59Fe into the medium from unopsonized bacteria incubated alone was 25.0 * 3.0% (mean -c SD for duplicate assays from nine experiments), which is considerably higher than at pH 5. This release was time-dependent, was not substantially less in HEPES compared with phosphate buffer, and since it was not affected by prewashing the E coli in EDTA, it was not due to solubilization of iron loosely bound to the surface. Plating assays suggested that it was probably due to bacteria dying during the incubation. Background release was decreased to 10.2 * 3.1% (four assays) when opsonized bacteria were used. The opsonization procedure gave recoveries of 65% to 75% of E coli with approximately 80% of their original specific activity, and may have removed compromised bacteria. Increases above the background level of release caused by the myeloperoxidase system were similar for the opsonized and unopsonized bacteria, and results in Table 1 have had backgrounds subtracted. These experiments also indicate that opsonization did not alter the susceptibility of the E coli to subsequent oxidant treatment.
There was a substantial increase in iron release when the E coli were exposed to the complete MPO system (Table 1) . H,O, alone had much less effect, and MPO-dependent release was more efficient with the higher amount of H,O, added. Methionine, which is a good scavenger of HOCI?' blocked MPO-dependent 59Fe release completely, and when the enzyme was inhibited with azide, release was decreased to that seen with H,O, alone. MPO, by converting H,O, to HOCI, should suppress the direct reaction between H,O, and the E coli in the presence or absence of methionine, and these results support MPO-derived HOCl as the agent responsible for releasing the iron from the bacteria when MPO was present. Iron release did not require citrate to complex the iron and was similar whether or not lactoferrin was present in the medium. Iron release was decreased in the presence of the higher concentration of transferrin. This is probably due to the protein scavenging some of the HOClZ9 and preventing it from attacking the bacteria, since casein at a higher concentration inhibited MPO-dependent iron release completely. The "Fe released from E coli treated with MPO at pH 7.4 was mostly in a low Mr form, with 85% passing through an ultrafiltration membrane with 10,000 Mr cutoff. This compares with 74% of the 59Fe released from bacteria incubated alone, and 29% of the 59Fe in an E coli sonicate. Addition of citrate to the separated supernatants gave small increases (5% to 15%) in ultrafilterable 59Fe.
To test whether the 59Fe released from the E coli by the MPO system was taken up by lactoferrin, lactoferrin-bound iron was precipitated using a specific antibody. It was shown first (Table 2) that adding excess lactoferrin and then anti-lactoferrin specifically precipitated 21% of the total iron in an E coli sonicate and 47% of the iron released from bacteria incubated in buffer, above the small amount precip itated nonspecifically with the control antibody. When the bacteria were treated with MPO and antilactoferrin was added to the separated supernatants, increasing concentrations of lactoferrin present during the incubation gave increasing amounts of 59Fe precipitated (Table 2) . With excess lactoferrin, almost all the 59Fe was precipitated. Lactoferrin added after treatment of the E coli with MPO bound a similar amount of iron to that added with the MPO (not shown). These values are only slightly less than the percentages of ultrafilterable counts, suggesting that a majority of the low Mr iron was available to complex with lactoferrin.
A similar experiment was carried out with transferrin added during exposure of E coli to MPO and precipitated with anti-transferrin antiserum. With 67 and 134 Kg/mL transferrin only 4.7% and 9.8%, respectively, of released counts were immunoprecipitated, much less than with equivalent concentrations of lactoferrin. Apotransferrin can be inactivated by MPO-derived oxidant^.'^ Such inactivation might be expected in the present study, since oxidant scavenging by transferrin was apparent (see above). Consistent with this interpretation, at least fourfold more "Fe was bound to transferrin added after the incubation.
Opsonized 59Fe-labeled E coli were mixed with neutrophils, and the fate of the 59Fe was studied. On mixing, there was a brisk uptake of oxygen, and degranulation occurred, as indicated by MPO release. Typically, as in Fig 2A, 40% to 50% of the bacteria Phagocytosis of "Fe-labeled E coli.
were phagocytosed (sedimented with the neutrophils in a low speed spin), during the first 10 minutes. The total phagocytosed counts were divided into those that remained associated with the bacteria and those that could be released by treating the sedimented cells with saponin. Hamers et alzl have shown that this treatment lyses neutrophils and releases their phagosomal contents, without lysing E coli. Consistent with this, we found that saponin treatment of "Fe-labeled E coli alone released only 4.5 0.3% (n = 2) of their 59Fe, compared with 5.7% in the PBS control.
59Fe was released by saponin treatment of the sedimented neutrophils. This is presumed to be iron that had been released from the bacteria into the phagosomes following ingestion. The proportion of total ingested counts in this fraction reached a maximum that varied between 9% and 40% (mean, 23%) for eight different neutrophil preparations. In all but two experiments, the maximum was reached within 10 minutes and then remained constant or declined slightly (as in Fig 2A) . In the other two experiments, as shown in Fig  2B, phagosomal 59Fe continued to rise during the incubation.
In the experiment shown in Fig 2A, the soluble 59Fe in the medium increased during the period of incubation. However, since uningested E coli were incubated with the neutrophils, iron in the medium could have come from either phagocytosed or free bacteria. Other experiments were performed, therefore, in which the neutrophils and bacteria that were phagocytosed in the first 10 minutes were separated from free bacteria and then incubated in fresh medium. In these experiments also, there was a clear increase in the medium of 59Fe that must have come from the phagocytosed E coli. One experiment is shown in Fig 2B; others gave similar trends, although there was some variability in the extent of iron release. Overall, 40 * 15% (n = 4) of the phagocytosed 59Fe
was released during the subsequent incubation period, with 25 * 10% of the total appearing in the incubation medium.
Addition of azide (2 mmol/L) to the neutrophils did not alter the extent of phagocytosis of E coli. However, the subsequent 59Fe release into the phagosomes and medium, measured after 10 minutes, was approximately half that with no azide present. In one experiment, there was 16% release of phagocytosed iron, compared with 38% in the absence of azide, and in another, the respective values were 20% and 33%. In the latter experiment, after 20 minutes, iron release in the presence of azide had increased to 28% whereas it had reached a maximum of 40% in its absence. Thus azide substantially decreased iron release, particularly in the early stages after ingestion. These results imply that myeloperoxidase plays a significant role in neutrophil-mediated release of E coli iron.
As shown in Fig 2B, the majority of the 59Fe released from the E coli into the phagosomes and into the medium was precipitated with anti-lactoferrin antiserum. The combined results of this and two other experiments, in which samples were taken a t three time points during the incubation, gave precipitation by the specific antibody of 46 3% of the phagosomal 59Fe and 62 6% of the 59Fe in the medium. Precipitation by the control antibody was less than 2%. With exogenous lactoferrin added to each of the supernatants in Fig 2B, excess anti-lactoferrin precipitated only about 5% more of the 59Fe, indicating that almost all of the iron available to lactoferrin was complexed.
DISCUSSION
We have shown that exposure of E coli to MPO, H202, and chloride at pH 7.4, as well as at pH 5,17 releases most of the bacterial iron, and that if lactoferrin (iron-poor) is present, it takes up most of the iron released. Most of the iron in E coli is present in iron-sulfur proteins, with a small fraction in heme protein^.'^.^^ We found that less than 30% of the 59Fe in an E coli sonicate was low molecular weight and able to bind to lactoferrin. Most of the iron released by exposure to the MPO system, therefore, must have come from proteins.
When labeled bacteria were phagocytosed by neutrophils, bacterial iron was released and detected both inside the neutrophils and in the surrounding medium. The intracellular iron was released by saponin, which lyses neutrophils and their phagosomes but not E coli,*' and it is likely that it was intraphagosomally located. The iron in the medium originated from phagocytosed E coli, since it still accumulated when uningested bacteria were removed. The time course experiments indicate, therefore, that bacterial iron release into the phagosomes begins soon after ingestion. Iron in the phagosomal pool quickly reached a maximum, suggesting that its release from the bacteria is balanced by release from the phagosomes into the medium.
Scavenger and inhibitor studies indicated that release of bacterial iron by the MPO system was due to enzymatically produced HOCl, although some release due to H202 was seen when MPO was absent or inhibited. In the neutrophil system, iron release was decreased substantially by azide. This suggests a major role for the MPO system. Iron release in the presence of azide could be caused by the higher concentrations of H202 that should accumulate when MPO is inhibited, although degradation of the bacteria by neutrophil hydrolases or proteinases may also contribute. Proportionally, less iron was released from phagocytosed E coli than from E coli treated with the isolated MPO system, even though, by inference from comparable studies,2'*26 most of the ingested bacteria should have been dead within 20 minutes. It has been shown that there is only a brief lag between killing by the MPO system and iron loss from the ba~teria."~'".~' This suggests that intracellular killing occurs without the extensive degradation of bacterial iron components expected if it were due solely to MPO.
The majority of the E coli iron released into the neutrophil phagosomes and into the medium was bound to lactoferrin. Of the remainder, very little complexed with excess lactoferrin, suggesting that it was still associated with bacterial proteins. Our results indicate, therefore, that iron is progressively released from phagocytosed E coli, mostly in a low Mr form that is bound by lactoferrin. With time, this ironlactoferrin is transferred from the phagosomes to the medium surrounding the cells.
Iron can catalyze free radical reactions such as hydroxyl radical production and lipid per~xidation.'~ It is also essential for bacterial Lactoferrin, provided it is not fully saturated, can be bacteriostatic by limiting iron availability.8 It also suppresses iron-dependent hydroxyl radical production and lipid per~xidation.''~'~~'' Therefore, the advantages of neutrophil lactoferrin complexing iron released from killed bacteria could be twofold: preventing both the growth of bacteria that survive the killing process'" and the occurrence of undesirable free radical reactions in the vicinity of the cells. The iron would also remain soluble and be transported away from sites of inflammation.
In order for lactoferrin to take up iron released from targets by stimulated neutrophils, its binding sites must not be destroyed by exposure to neutrophil oxidants. Neutrophil granule constituents can be inactivated by MPO-dependent proce~ses.'"'~ We found that lactoferrin present during exposure of E coli to the MPO system retained its ability to bind iron. Under similar conditions, transferrin took up much less of the released bacterial iron, and oxidative inactivation was suggested. This is in keeping with the approximately fourfold greater sensitivity of apotransferrin compared with apolactoferrin to MPO-dependent destruction of the iron binding site:9 and shows how the relative resistance of lactoferrin would be an advantage in the phagosome.
We have shown that most of the iron released from phagocytosed E coli is complexed by neutrophil lactoferrin. Neutrophils, through a superoxide-dependent mechanism, can also release iron from the iron storage protein, ferritin.17 Bullen and Armstrong'" have shown that neutrophil lactofer-rin becomes saturated when ferritin-antiferritin immune complexes are ingested, and we have found" that lactoferrin takes up iron released from ferritin by superoxide and inhibits ferritin-dependent lipid peroxidation. We propose, therefore, that one function of neutrophil lactoferrin is to take up iron from bacteria or surrounding tissue that the cells destroy, and suppress its prooxidant activity.
